Table 3.
Bivariate Analysis to Identify Risk Factors Associated With AKI
| No AKI, No. (%) | AKI, No. (%) | P Value | |
|---|---|---|---|
| AUC >550 | 58 (58) | 42 (42) | <.005 |
| Age >70 y | 52 (67.5) | 25 (32.5) | .005 |
| Duration >7 d | 130 (78.3) | 36 (21.7) | .813 |
| CrCl <50 mL/min | 17 (63) | 10 (37) | .043 |
| Piperacillin-tazobactam | 56 (71.4) | 16 (28.6) | .162 |
| Cefepime | 62 (79.5) | 16 (20.5) | .685 |
| Ceftriaxone | 33 (78.6) | 9 (21.5) | .920 |
| Nephrotoxic comorbidities | 91(71.7) | 36 (28.3) | .004 |
Abbreviations: AKI, acute kidney injury; AUC, area under the curve; CrCl, creatinine clearance.